Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Our founder, Prof. Thomas Bieber, published an important contribution in the treatment of AD: Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spectrum of clinical phenotypes. AD remains challenging to treat owing to the limited response to available therapies. However, recent advances in understanding of […]
